Neuroendocrine tumour of the mediastinum: Fusion of 18F-FDG and 68Ga-DOTATOC PET/CT datasets demonstrates different degrees of differentiation

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 5, 2007, Pages 812-

  Von Falck, C ^a   Boerner, A R ^b   Galanski, M ^a   Knapp, W H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Brüderkrankenhaus ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; OCTREOTIDE[3 TYROSINE 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID] GA 68; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMALE; HUMAN; IMAGE ANALYSIS; LUNG INFILTRATE; MEDIASTINUM TUMOR; NEUROENDOCRINE TUMOR; PLEURA EFFUSION; RADIATION DOSE; TUMOR RECURRENCE;

FEMALE; FLUORODEOXYGLUCOSE F18; GALLIUM RADIOISOTOPES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEUROENDOCRINE TUMORS; OCTREOTIDE; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34247566147     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0350-9     Document Type: Article

References (3)

1. Adams S, Baum R, Rink T, Schumm-Dräger PM, Usadel KH, Hör G. Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumors. Eur J Nucl Med 1998;25:79-83.
2. Maecke H, Hofmann M, Haberkorn U. 68-Ga-labeled peptides in tumor imaging. J Nucl Med 2005;46 Suppl 1:172-8.
3. 90Y-DOTATOC therapy. Eur J Nucl Med Mol Imaging 2006;33:1115-22.